|
|
||||||||
Ann Thorac Surg 2002;73:1995-2004
© 2002 The Society of Thoracic Surgeons
a Division of General Thoracic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
b Department of Surgery, Harvard Medical School, Boston, Massachusetts, USA
* Address reprint requests to Dr Grillo, Massachusetts General Hospital, Blake 1570, 55 Fruit Street, Boston, MA 02114 USA
e-mail: pguerriero{at}partners.org
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In the 1950s and 1960s, experimental investigation of the potential extent of tracheal resection with primary anastomosis by anatomical mobilization and without prosthesis [37] greatly widened these possibilities. Approximately half of the adult trachea could be removed surgically and reanastomosis performed. Although a great expansion of tracheal surgical procedures followed application these principles, investigators continued to seek tracheal replacement for those relatively few lesions, chiefly neoplastic, that could not be managed by the techniques thus developed [8, 9].
The categories of tracheal replacements that were explored are reviewed here in some detail, although complete review is nearly impossible, so attracted have surgeons been by the illusory simplicity of developing a conduit to replace native trachea. No predictable and dependable replacement has yet been found. The intent of this review is not to discourage thoughtful exploration toward this goal, but to provide information that may forestall fruitless repetition of past failures. To this end, fundamental biological constraints have been emphasized. Considerable additional literature in German, French, and Japanese has been slighted, and apology is made for these oversights.
| Need for tracheal replacement |
|---|
|
|
|---|
| Requirements for replacement |
|---|
|
|
|---|
Other authors [14, 15] have added further that materials for tracheal replacement must be biocompatible, nontoxic, nonimmunogenic, and noncarcinogenic; must not dislocate or erode over time; ideally should provide or facilitate epithelial resurfacing; should avoid stenosis or late buckling; should resist bacterial colonization; should avoid accumulation of secretions; and must be permanent constructions.
| Approaches to replacement |
|---|
|
|
|---|
The technique of lateral tracheal excision, principally for tumors, was practiced for many years, because of fear of creating tracheal discontinuity, which, it was believed, could not be reapproximated. The defect in the trachea was patched with a variety of foreign material and tissues [8]. The technique has been abandoned largely because of the frequency of recurrence of tumor due to inadequate margins resulting from the compulsion to save sufficient tracheal wall for structural reason. Also, necrosis and leakage of devascularized patches was often fatal, if they occurred in the mediastinum. However, combinations of vascularized tissue flaps (such as pericardium) and supporting foreign materials (such as Marlex) did succeed in healing in some cases, even if they were rarely successful oncologically.
| Foreign materials |
|---|
|
|
|---|
Solid prostheses
Foreign materials were used early on to form tubular replacements for resected trachea. The trachea was replaced experimentally, most often in dogs, with tubes of stainless steel [17, 18]; tight coils of steel wire [19]; Vitallium [4, 17]; glass [17]; polyethylene [16, 2024]; Lucite [4, 19]; silicone [2528]; Teflon [18, 29, 30]; Ivalon [4, 31]; polyvinyl chloride [32]; polyethylene, polyurethane, silicone elastomer, and Teflon combinations [33]; rigid and flexible silicone elastomer with Dacron cover [34]; and tubes of Teflon, Ivalon, and silicone elastomer [35].
Solid prostheses were also tried clinically in occasional cases: stainless steel [36, 37], steel coil [19], silicone [38, 39], polythene (polyethylene) [40, 41], Teflon [42], polyethylene and Tantalum [33], and Lucite [20]. Anastomoses after short resections were also carried out over splinting polythene stents [43].
Borrie and colleagues [26, 27] added suturable subterminal fabric cuffs to a silicone prosthesis, which was intussuscepted into the tracheal ends (experimentally in sheep), to prevent granulation tissue from obstructing the lumen and to encourage fixation of the prosthesis. Neville and his colleagues [38] used a similarly cuffed silicone tube clinically. Toomes and coworkers [39] experienced obstructive granulation tissue, migration, and vascular erosion with the same prosthesis. I personally have seen patients in consultation who had severe, recurrent, and insoluble granulation tissue obstruction at either end of a Neville prosthesis. Long segments of normal trachea had been excised to remove shorter stenotic lesions to accommodate the nonadjustable prostheses. In a number of patients, the original lesion could have been easily managed with a short resection and end-to-end anastomosis. Later, the prosthesis was placed inside an unresected stenotic trachea, where a silicone stent or T tube might have served better.
Solid prostheses, despite some successes for varied lengths of time, eventually tended to migrate, become dislodged, obstruct with granulation tissue at either end with subsequent stenosis, and encourage infection at the interface between foreign material, tracheal epithelium, and the granulation tissue bed. Erosion of the brachiocephalic artery not infrequently followed with fatal result. Complete epithelization rarely occurred beneath the prosthesis. Despite all of these complications, a rigid prosthesis can maintain an open airway for some time, despite a lack of healing. Such a result, however is, episodic and unpredictable. Daniel [17] mistakenly believed that tracheal rings regenerated structurally over a solid tube and Longmire [20] appeared to accept this unlikely event.
To date, nearly all surgical prostheses that have been successfulvascular conduits, heart valves, orthopedic deviceshave been sited in potentially sterile mesenchymal tissues. No example of comparable success can be cited in the respiratory, gastrointestinal, or genitourinary tract. Here an interface inevitably persists among foreign material, chronically repairing connective tissue, and epithelium, which is a source of bacterial contamination. Trials of one material after another cannot be expected to solve this basic biological incompatibility.
Porous prostheses
To counter the usual failure of impervious solid prostheses, meshes made from a wide selection of materials were used experimentally. The porous structure was calculated to permit ingrowth of host connective tissue, incorporating the prosthesis into the tracheal site. It was found that a minimal porosity of 40 to 60 µm is necessary for capillary ingrowth [15]. It was hoped that this bed of autogenous new connective tissue would serve as a base for migration of adjacent tracheal epithelium. Regeneration of epithelium was described, with evolution from squamous to cuboidal to pseudostratified to ciliated cells [44, 45]. Meshes were sometimes supported with wire, plastic rings, or coils and sealed with tissues (such as omentum, fascia, pericardium) or biopolymers (such as fibrin sponge or reconstituted collagen) to prevent early air leakage. Experimental meshes included steel wire [16, 19, 24, 30, 4648] variously wrapped with tissue for air tightness; stainless steel wire lined with dermis or various synthetic materials [18]; Tantalum [1, 3, 19, 24, 30, 4951] with or without pleura or fascia; coated titanium fiber metal [52]; Marlex [24, 47, 53, 54]; Marlex with collagen [55], or with collagen reinforced by a polypropylene spiral [56, 57]; polytetrafluoroethylene (PTFE) [30, 5862]; polyurethane [63]; Ivalon and wire [4, 64, 65]; Dacron and polyurethane [66]; and Teflon [30, 41].
The list of combinations is almost endless. Dacron was used [67] in patches of low and high porosity, with sloughing of the low-porosity material and eventual incorporation and epithelization of small patches of high-porosity Dacron over a prolonged period [66]. Experimental Z-plasty allowed tracheal approximation by relaxation and the sites of Z-plasty were patched with Dacron [68]. McCaughan [69] noted that silicone elastomer-reinforced Dacron produced granulations and stenosis. Surprisingly, ready incorporation of connective tissue and epithelization (in 5 to 7 weeks) of a 5-cm Gore-Tex (W.L. Gore and Assoc, Flagstaff, AZ) tube with reinforcing rings was reported [70], but details of epithelization and long-term results were lacking. Ingrowth of connective tissue in Dacron prostheses led to narrowing and obstruction [71]. Wide mesh Teflon with polypropylene rings [41] with an inner liner of solid polypropylene tube was also attempted.
Meshes were also used clinically as patches [72] or circumferentially: steel wire [19, 46]; Tantalum covered with fascia lata [73]; or skin and Tantalum gauze [74]; heavy Marlex [54, 7578] sometimes covered with pedicled pericardium; and Ivalon and wire [63]. Pagliero and Shepherd [79] managed late postoperative dehiscence of the trachea by operative insertion of a stainless steel wire coil to splint open a connecting conduit of partly epithelized scar tissue.
Connective tissue ingrowth served to fix and incorporate some porous prostheses as noted. However, the continued proliferation of scar tissue most often led to obstruction and stenosis. Frequently, large sections of mesh, especially in longer segment replacements, remained uncovered by connective tissue and bacterial colonization followed. Epithelium generally failed to migrate sufficiently to cover the entire neotracheal surface, allowing continued cicatrix formation, usually in the center of the replacement [8]. Although very short interpositions might achieve full epithelization, which seemed to prevent further cicatrization, the rate and completeness of epithelial migration was usually insufficient to prevent central granulations, cicatrization, and stenosis. Obviously, very short tracheal replacements offered no solutions to the problem addressed.
Pearson and colleagues [54] endeavored experimentally to provide a source of epithelization by advancing partially detached terminal rings of cartilage, with mucous membrane intact, obliquely over Marlex replacements. Stenotic obstruction and brachiocephalic artery erosion attended some Marlex tracheal replacements in humans [54, 78] and experimental animals. Death occurred similarly with steel mesh prosthesis [19]. Marlex mesh that fails to become fully covered harbors bacteria (notably Pseudomonas aeruginosa), which produce purulent sputum and foul odor. One patient, who over many years had lost his wife, his job, and his friends because of intolerable halitosis from a Marlex reconstruction of cervical trachea, was finally relieved by its excision and placement of a silicone T tube. Thus, the dual problem of infection or of granulation tissue and scar formation, sometimes in irregular patterns, tends to prevent even incorporation of porous prostheses [41]. An impervious inner liner prevents the overgrowth of obstructing granulation tissue, but full epithelization was not seen and such an internal liner can never be removed [41].
| Implantation of nonviable tissues |
|---|
|
|
|---|
Experimentally, Scherer and associates [15] processed rat, guinea pig, and pig tracheas chemically, including tanning with glutaraldehyde, and variously implanted tracheal segments and window patches as autografts, allografts, and xenografts. Rejection seemed to be avoided. Variable long-term morphologic survival of cartilage and epithelization occurred in rats, but not in pigs. Pressman and Simon [23] used sterilized and lyophilized aortic homografts over polyethylene tubes in dogs to exclude granulation tissue. Stenosis was prevented by the stent, but linear contraction stretched and deformed the proximal and distal ends of the trachea. The damaged rings calcified and tracheal epithelium surfaced the aortic graft. Marrangoni [81] in 1951 and Greenberg and Williams [82] in 1960 observed that lyophilized canine tracheal allografts lost their cartilage and were replaced by scar tissue. Björk and Rodriguez [31] implanted freeze-dried, formalin fixed. and 95% alcohol-treated allografts, with fatal stenosis or necrosis in all. Related laboratory experiences are described below in the section on Allografts: Preserved, Devascularized. These experiences are included in the Tracheal Transplantation section for completeness, because many investigators analyzed both fresh and preserved grafts in their experiments.
More recently, this avenue has been reexplored. Clinically, cadaver tracheal graft fixed in formalin and stored in merthiolate, implanted and observed more than 13 months, showed histologic disintegration and reduced allogenicity [83]. Jacobs and colleagues [84] further described "tracheal allograft reconstruction" in adults and children, using cadaver trachea treated with 4% formalin, followed by thimerosal, and stored in acetone. The cartilaginous portion of long stenoses of various etiologies (or the anterolateral portion in the case of congenital O-rings) were excised and replaced with the fixed tissue, supported by Dumon or Hood silicone intraluminal stents. Frequent bronchoscopy was necessary to remove exuberant granulation after stent removal, but complete epithelization was described after unspecified intervals, based on bronchoscopic visualization and histologic samples. Of 6 patients, 1 died of innominate artery fistula, 2 had tracheomalacia requiring stents, 1 with stent replacement subsequently removed "recently" needed frequent bronchoscopy for granulations, 1 underwent stenting with a tracheostomy tube, and 1 (operated on 6 months previously and who needed a tracheostomy tube) underwent decannulation for an unspecified time [84]. In summary, 1 patient in 6 was free of stents with an adequate airway over short term [84]. Somewhat better results were cited for 18 of 31 children (58%) so treated in Europe, but detailed follow-up data were not given to permit full appreciation of final their status [85].
If full epithelization does occur by migration of tracheal epithelium from the intact posterior wall strip, it must be over host granulation tissue that has replaced the cadaveric graft. This occurrence would explain the exuberant granulations described and also the development of serious malacia as the dead cartilage is resorbed and replaced by cicatrix. It is biologically inconceivable that wholly dead cartilage could become reconstituted as living cartilage. In effect, we appear to be dealing with an oversized patch tracheoplasty using fixed tissue rather than fresh autologous costal cartilage or pericardium. Indeed, in an earlier commentary, some authors [86] stated that the graft "becomes very fibrotic according to the samples of the few patients ... who have died ... There is no live cartilage in the donor trachea."
| Autogenous tissues |
|---|
|
|
|---|
Clinically, in 1943 and 1944, Belsey [2] performed two radical tracheal resections for "cylindroma," leaving a narrow strip of tracheal wall intact and reconstructing the defect with fascia lata supported by a coil of steel wire. Clagett and colleagues [40] also used this technique. A free bronchial patch [105] and free fascia lata [106] were also used in patients, the latter as early as 1912. The use of wire-supported dermal grafts to widen bronchi and trachea was extensively reported in the 1950s [107, 108]. Larger dermal grafts for tracheal repair were frequently unsuccessful [109, 110]. Dermal grafts wrapped around Tantalum tubes failed when used intrathoracically [12]. A patch of auricular cartilage was used to widen the lower trachea [111]. Free fascial grafts in small tracheal windows healed and epithelized [112]. Crafoord and Lindgren [113] used skin and cartilage to repair cervical trachea in 1945.
Costal cartilage [114] and, later, pericardium [115] were successfully used as patch grafts for treatment of long congenital stenosis, without specific revascularization. Only occasionally did necrosis occur [116]; re-epithelization was noted [104]. Pericardium was replaced with mature scar tissue [104]. Tracheal growth was also reduced [117]. Even with addition of an omental pedicled flap [118], a cartilage patch is in time resorbed.
Vascularized autogenous tissue flaps
Another route of reconstruction, either as a flap for tracheal repair after lateral or "window" resection or as a tube after circumferential resection, was to use the patients own tissues, preserving or reanastomosing the blood supply. Because relative rigidity is necessary, free grafts of cartilage, plastic rings, or meshes were added for support. Foreign material or cartilage autografts were implanted in mesenchymal tissue. In general, lateral resection of tumor is not favored because of the likelihood of inadequate resection, as well as problems in healing of free tracheal patches, especially when the patches are intrathoracic. A vascularized patch is less likely to necrose than a free patch. On rare occasions, this technique is still used when a long segment of lateral tracheal wall must be removed to obtain complete resection of an invasive secondary neoplasm. Where circumferential resection is not possible because of the length of neoplastic involvement, lateral excision of the wall and reconstruction with a pedicled pericardial flap supported by materials such as Marlex may be effective.
Experiments in vascularized flap repair of window defects have included pedicled intercostal muscle patch graft [119], pedicled periosteum [91], pedicled bronchus [120], and rib and pleural transfer with microvascular anastomosis for long anterior tracheal defects in dogs [121]. Half of these latter animals survived. Lofgren, Lindholm, and Jansson [122] performed in three stages a pedicled composite graft of buccal mucosa and Proplast (PTFE and pyrolytic graphite), with a connective tissue "external" layer, for repair of lateral tracheal defects in beagles.
Clinically, Nowakowski [123] used local skin flaps in 1909 to close cervical tracheal defects. Other flaps used have included pedicled intercostal muscle and pleura [124], without the wire supports for flaps that had been previously used in dogs; periosteum on a muscular pedicle for lateral repair [125]; rotated bronchus [126]; pedicled diaphragm to posterior tracheal wall [127]; and pedicled patch of pericardium supported by Marlex for repair of a long lateral defect (J.C. Wain, unpublished). A pedicled intercostal periosteal flap was used to repair tracheoesophageal fistula [128].
The use of cartilage grafts and hyoid bone transfers to enlarge the stenotic larynx either anteriorly or posteriorly is an extensive topic by itself [129] and will not be discussed here.
Autogenous tube construction
The cervical trachea has been reconstructed experimentally by formation of a cutaneous trough, supported by cartilage or plastic rings, with staged closure of the trough [12, 130, 131]. Edgerton and Zovickian [12] reviewed early attempts at creation of skin flaps, including tubed pedicles, supported with rib or costal cartilage and sometimes lined with split grafts. In 1964, Grillo and associates [6] designed a staged repair of the cervical trachea to replace a cervical tracheal segment devolved with its blood supply into the mediastinum for primary intrathoracic anastomosis. A cutaneous tube was formed in stages, supported by polypropylene rings inserted between dermis and the attached platysma [131]. In 1939 Serrano and colleagues [132] inserted a series of bilateral hemi-rings of cartilage carved from costal arch to provide support when a skin trough was finally closed anteriorly.
Doctors Joo Hyun Kim and H.C. Grillo (unpublished) constructed staged tracheal replacements in dogs by allowing the perichondrium of two costal cartilages to form a cartilaginous tube around a silicone mold in situ, later lining this tube with buccal mucosa, and, finally, transferring it to a thoracic site with blood supply from the still-attached but mobilized intercostal muscle pedicles. As might be expected in such a complex repair, only a percentage of preparations fully succeeded. The work was, therefore, not published.
Papp and colleagues [133] wrapped intercostal muscle, stiffened with cartilage and lined with skin around a stent, in dogs. The complexity of the procedure led to high mortality. Krespi and colleagues [134] wrapped a pleural periosteal flap around a silicone elastomer stent and after 6 weeks in a subcutaneous location, moved the tube to an orthotopic location, but with uncertain results. Botta and Meyer [135] used a rat model and prepared in multiple stages a connective tissue tube with allografts of tracheal cartilage, previously prepared to reduce antigenicity, around a silicone elastomer tube, later lined with buccal mucosa, with regional supply from implantation. Their tube was eventually anastomosed by microsurgical technique to cervical vessels. The complexity was clinically daunting. Kon and Van den Hooff [136] also produced cylinders of cartilage by wrapping rib perichondrium around a silicone rod implanted in tissue.
Another line of experimental reconstruction with host tissue has been the use of adjacent esophagus to replace a long segment of trachea. Mural splinting is required to maintain patency, although, amazingly enough, in some experiments the splinting seems to have been unneeded. In my laboratory, placement of a series of discontinuous polypropylene rings failed when the adjacent supported segments caused obstruction by sliding laterally. A suggestion that an esophageal segment be substituted for trachea just to provide a channel for a T tube [137] seems to overlook the magnitude of operation that is then needed for esophageal replacement. In an effort to avoid the necessity of a major operation for later esophageal replacement, revascularized segments of small intestine have also been used experimentally [138]. Given the collapsibility of small intestine, it is difficult to understand how respiration was possible, unless the interposed segment was very short.
Clinically, multistaged cutaneous tubes have been widely used for construction of cervical trachea. Multiple trough techniques have been devised and used [12, 139149]. Edgerton and Zovickian [12] attained success in multistaged flap reconstruction of cervical trachea clinically. Grillo [13] described clinical application of his two-staged technique. Although successful in a few patients, the technique is not recommended because of an overall low success rate. It should be noted that staged repairs of the type listed have no application intrathoracically where an airtight airway must be attained immediately. Failure of healing, likely to occur in some cases after complex repairs, could cause fatal mediastinitis in the chest.
Esophagus in situ has also been used to patch the membranous tracheal wall and to serve as a long linear patch for congenital stenosis [150, 151]. Fonkalsrud and colleagues [152, 153] tried unsuccessfully to replace trachea with a segment of esophagus for agenesis and for stricture.
| Tissue engineering |
|---|
|
|
|---|
| Tracheal transplantation |
|---|
|
|
|---|
Mayer and coworkers [162] found that continuous local infusion of basic fibroblast growth factor appeared to enhance early revascularization and epithelial regeneration in tracheal isograft segments in rats when implanted in omentum. Olech and colleagues [163], in contrast, detected no beneficial effect of growth factor, but basic fibroblast growth factor was administered as a single local application in a carrier.
Allografts: fresh, devascularized
Fresh tracheal allografts without aid of immunosuppressive therapy initiate rejection [161, 164166]. Uniform failure of fresh allografts of any length occurs [12, 25, 35, 89, 159], even with immune suppression (Imuran, Decadron) in the absence of revascularization. Neville and associates [159] identified the same processes as seen with autografts, with survival only in very short grafts in which the resulting fibrous tissue was too limited to obstruct the lumen. With longer allografts, all dogs died. Allografts of partial tracheal wall removal [167] prevented obstruction, but grafts were replaced by flaccid scar.
Fresh tracheal allografts were early demonstrated to necrose and liquefy [14], or, if short, to result in fibrous stenosis [3, 49, 161, 168, 169]. Beigel and coworkers [164] found from experimentation in inbred rats that tracheal transplants carry antigens and have an immunogenic action from the donor, and that mucosa is rejected and replaced by recipients cells. Hence, they concluded that tracheal transplants follow the same rules as other tissues in opposition to the earlier belief that the trachea had weak antigenicity [170]. Bujia and colleagues [165] also agreed that mucosa from human trachea was likely the major antigenic structure responsible for immunogenic action of tracheal allografts.
Allografts: preserved, devascularized
In 1950, Jackson and coworkers [14] found that partly de-epithelized, Merthiolate-treated, and cold-preserved canine allografts failed in repair of extensive defects. Cartilage resorption and scar replacement produced collapse and obstruction. In 1952, Davies and colleagues [171] found that fresh canine allografts preserved in Tyrodes solution or 4% formaldehyde narrowed to complete obstruction in 1 to 3 weeks. Epithelium and cartilage disappeared and fibrosis occurred. Pacheco and colleagues [161] described destruction and fibrosis of fresh allografts (short enough so that autografts in concurrent experiments survived), and stenosis of allografts preserved in alcohol or saline or when lyophilized. Björk and Rodriguez [31] confirmed this finding in grafts preserved in Tyrodes solution at -4°C, lyophilized grafts, and in grafts formalinized or preserved in alcohol. Keshishian and coworkers [19] observed liquefaction and necrosis of canine allografts preserved in Tyrodes solution at -4°C. Cryopreserved cartilaginous allografts placed on tracheal window defects in piglets appeared to survive with some resorption and become epithelized [172].
Keshishian and colleagues [19] also transplanted six-ring allografts in dogs after about 2 weeks of preservation in Tyrodes solution. All necrosed. Diced autogenous costal cartilage molded between glass and stainless steel mesh survived in rectus muscle, but not as a tracheal replacement. When half the cartilage was allograft, the implant failed in muscle, too. Lenot and associates [173] used a pig model and demonstrated necrosis of devascularized tracheal allografts pretreated with glutaraldehyde, glycerol, lyophilization, or cryopreservation. Immunosuppressive agents and steroids were not given. All died from resulting airway obstruction. Although response varied somewhat in accordance with methods of preservation, the results were uniformly disastrousthe result of ischemic necrosis of epithelium, submucosa, and cartilage [173].
This slow accumulation of evidence in both autografts and allografts treated in a variety of ways clarified that blood supply was critical if successful tracheal transplantation was ever to be possible. Macchiarini [174] summarized as follows: "(D)evascularized tracheal allografts necrose whatever the conservation procedure. Only a living substitute, therefore vascularized, can pretend to fulfill the anatomic mechanical and antiinfectious functions of the trachea."
Vascularized grafts
Revascularization of an orthotopic tracheal graft can be accomplished indirectly with pedicled omentum, intercostal muscle, musculofascial flap, or other pedicles, or directly by vascular anastomoses.
Autografts: fresh, indirectly vascularized
Several researchers [175177] used omentopexy to revascularize free tracheal grafts in rats and in dogs with considerable success. Nakanishi and associates [160] demonstrated that omental wrapping allowed fresh tracheal autografts to recover from the early ischemic changes as new vessels connected to the graft. Morgan and colleagues [178] had earlier demonstrated the neovascularizing potential of omentum for bronchi. Fell and colleagues [179] found an intercostal pedicle flap to function similarly in bronchial autografts. Li and colleagues [180] noted better vascularization and survival of autografts initially reimplanted in the omentum abdominally and transferred 2 weeks later to a tracheal site on an omental pedicle.
However, even with omental revascularization, canine autografts longer than 4 cm (8 to 10 rings) frequently showed stenosis or dissolution in their central portions due to ischemia [181]. Introducing omentum into an autograft split at the midpoint did, however, provide vascularity sufficient to prevent central graft necrosis [182]. Balderman and Weinblatt [183] did not find that omental wrapping sustained chondrocyte viability in eight-ring tracheal autografts in dogs. Li and associates [180] improved epithelial and chondrocyte survival by preliminary implantation of autografts into omentum about 2 weeks before transfer to an orthotopic location. Others [184, 185] showed survival of omental-wrapped autografts with normal histologic structure. Murai and colleagues [186] removed cartilage rings from long autografts to improve omental contact and revascularization of epithelium.
Allografts: fresh or preserved and indirectly vascularized
Fresh allografts with omental revascularization have failed, most probably due to rejection [183185, 187189]. Recovery of epithelium from initial damage before establishment of vascular supply from omentum, which is seen in autografts, failed to occur in allografts [190]. Cryopreserved allografts with omental flap revascularization survived without immunosuppressive therapy [184, 185, 191]. Cryopreservation seems to inhibit allogenicity while structural integrity appears to be maintained. Mukaida and coworkers [192] observed gradual replacement of graft epithelium by recipient epithelial cells after 50 to 60 days. Deschamps and associates [193] noted some deterioration of cartilage in allografts implanted in abdominal muscle for vascularization, despite cryopreservation. Other tracheal elements seem to be unchanged. Moriyama and associates [194] found that cryopreservation of allografts reduced acute rejection and permitted early revascularization, but that chronic rejection then led to vascular occlusion and atrophy.
Tojo and coworkers [195] in orthotopic cryopreserved tracheal allografts in rats without immune suppression also identified the late (2 months) graft epithelium to be of recipient origin while the chondrocytes were of donor origin. They concluded that recipient origin of epithelium over the donor trachea accounted for the reduced antigenicity of the cryotransplanted trachea. Inutsuka and colleagues [196] noted the feasibility of cryopreservation of tracheocarinal allografts in dogs (for 3 weeks at -80°C) and subsequent viability in 75% without immunosuppressive therapy. The effectiveness of cryopreservation is unexplained.
Based on the likelihood that the mucosa and not the cartilage is the major antigenic structure of the trachea, Liu and coworkers [189] removed epithelium with a detergent. Omental revascularization was provided. Cartilage remained viable. Allografts (without immunosuppressive therapy) were incorporated without stenosis, compared with granulation tissue formation and stenosis in untreated controls. Yokomise and colleagues [187] reported long-term (longer than 1 year) survival of heavily irradiated five-ring allografts (100,000 cGy) with an omental pedicle for vascularization. No immunosuppressive therapy was given. This survival is likely the result of ablation of tracheal epithelium by irradiation, because the epithelium seems to have strong antigens [164], whereas cartilage does not [197].
Major histocompatibility complex antigens (MHC II, MHC I) are expressed in epithelium and mixed glands of the trachea and not in cartilage [165]. Moriyama and colleagues [188] found that immunosuppressive therapy was essential for tracheal graft survival along with omentopexy in dogs. Davreux [198] showed that tracheal allograft viability in rats, wrapped in omentum and heterotopically implanted, was improved with cyclosporin A. Central portions of longer grafts were less well-vascularized. Late endothelial repopulation by host cells was cited. The trachea survived where control skin grafts did not. Ueda and Shirakusa [199] experienced failure in four of six carinal allografts in dogs with omental wrapping and immunosuppressive therapy. Failure was attributed to failure of blood supply, even in short-segment grafts. Delaere and colleagues [200, 201] concluded that initial heterotopic tracheal transplantation (in rabbits), using a fascial vascular carrier flap with a 2-week delay to orthotopic placement with immunosuppressive therapy, improved success in allotransplantation.
Clinical tracheal allotransplantation has been tried in humans, with success reported in 1 patient after 9 weeks [170]. The donor trachea was first implanted heterotopically in the sternocleidomastoid muscle and pedicled orthotopically in 3 weeks. No immunosuppressive therapy was used. In another human long-segment allograft with omental revascularization and immunosuppressive therapy, necrosis and stenosis occurred, requiring a stent that could not be removed [202]. Its "success" must be questioned.
Direct revascularization
The arterial and venous supply of the trachea does not lend itself easily to direct revascularization. The vessels are of tiny diameter and segmental in distribution. Khalil-Marzouk [203] faced this problem by preparing a composite thyrotracheal graft, anastomosing the thyroid artery to the common carotid artery. Venous anastomosis was not done. In the absence of immunosuppressive therapy, cartilage was preserved but tracheal soft tissues necrosed. With cyclosporin and hydrocortisone, all tracheal tissues survived.
Macchiarini and colleagues [204], in a heterotopic pig model using cyclosporin, observed preservation of tracheal grafts, including epithelium, but only when both arterial and venous anastomosis was accomplished. Venous infarction occurred in the absence of venous anastomosis. Khalil-Marzouks observations are difficult to reconcile with this result. Grafts were 9 to 11 cm long. Isolated areas of submucosal necrosis, especially in membranous wall, repaired within a week [205]. These investigators also explored experimental thyrotracheoesophageal transplantation [206], adding perfusion of the arterial system of the graft with Euro-Collins solution.
In double-lung transplantation, direct bronchial artery revascularization has been done to prevent the still major threat of ischemia at the tracheal anastomosis. Couraud and colleagues [207] harvested an aortic patch at the origin of the right intercostobrachial artery connecting it to the recipient aorta with a saphenous vein graft. Daly and colleagues [208] anastomosed the largest bronchial artery in a patch of donor descending aorta to the left internal thoracic artery.
Strome and associates [209] described fresh laryngeal transplantation with complete HLA matching, which included a five-ring segment of trachea, thyroid, and parathyroids, and a portion of attached pharyngeal wall, plus both superior laryngeal nerves and right recurrent nerve, to replace a totally scarred larynx due to trauma years previously. Arterial, venous, and neural anastomoses were done, and perfusion was established early in the procedure. Over time, the patient regained vocal cord function and normal deglutition. Despite one episode of rejection, health and function were good at 40 months, with continued immunosuppressive therapy [209]. This success, if generally repeatable, would seem to encourage a similar trial for the trachea. However, the quality of life issues involved in providing a functional larynx and voice are not comparable with providing a conduit for the trachea. Because tracheal transplantation would presently be applicable only to benign disease, the efficiency and safety of a T tube currently in use must be compared with the hazard of operation and the chronic disease state of immunosuppressive therapy now necessary for any tracheal transplantation.
| Conclusions |
|---|
|
|
|---|
| Selected references * |
|---|
|
|
|---|
| Footnotes |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Abbasidezfouli, D. Sharifi, F. Sasani, D. Ansari, M. Abarkar, N. Rahmanijoo, G. Abbasidezfouli, and K. Sheikhy Using tracheal segments for replacement of cervical oesophagus: an experimental study Eur J Cardiothorac Surg, October 18, 2011; (2011) ezr010v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wurtz, I. Hysi, C. Zawadzki, V. Soenen, T. Hubert, C. Banfi, R. Jashari, and M.-C. Copin Construction of a tube-shaped tracheal substitute using fascial flap-wrapped revascularized allogenic aorta Eur J Cardiothorac Surg, October 18, 2011; (2011) ezr012v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Charokopos, C. N. Foroulis, E. Rouska, M. N. Sileli, N. Papadopoulos, and C. Papakonstantinou The management of post-intubation tracheal stenoses with self-expandable stents: early and long-term results in 11 cases Eur J Cardiothorac Surg, October 1, 2011; 40(4): 919 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jungebluth and P. Macchiarini Stem cell-based therapy and regenerative approaches to diseases of the respiratory system Br. Med. Bull., September 1, 2011; 99(1): 169 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Naito, T. Tojo, M. Kimura, Y. Dohi, W.-H. Zimmermann, T. Eschenhagen, and S. Taniguchi Engineering bioartificial tracheal tissue using hybrid fibroblast-mesenchymal stem cell cultures in collagen hydrogels Interact CardioVasc Thorac Surg, February 1, 2011; 12(2): 156 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsukada, S. Gangadharan, R. Garland, F. Herth, M. DeCamp, and A. Ernst Tracheal Replacement With a Bioabsorbable Scaffold in Sheep Ann. Thorac. Surg., December 1, 2010; 90(6): 1793 - 1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Agathos, P. Tomos, E. Lachanas, H. Gakiopoulou, A. Pantopoulou, and D. Perrea Experimental Replacement of Pig Trachea with Novel Bioprosthesis from Harp Seal Asian Cardiovasc Thorac Ann, December 1, 2010; 18(6): 557 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wurtz, H. Porte, M. Conti, C. Dusson, J. Desbordes, M.-C. Copin, and C.-H. Marquette Surgical technique and results of tracheal and carinal replacement with aortic allografts for salivary gland-type carcinoma J. Thorac. Cardiovasc. Surg., August 1, 2010; 140(2): 387 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Radu, A. Seguin, P. Bruneval, A. Fialaire Legendre, A. Carpentier, and E. Martinod Bronchial Replacement With Arterial Allografts Ann. Thorac. Surg., July 1, 2010; 90(1): 252 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perez del Palomar, O. Trabelsi, A. Mena, J. L. Lopez-Villalobos, A. Ginel, and M. Doblare Patient-specific models of human trachea to predict mechanical consequences of endoprosthesis implantation Phil Trans R Soc A, June 28, 2010; 368(1921): 2881 - 2896. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Go, P. Jungebluth, S. Baiguero, A. Asnaghi, J. Martorell, H. Ostertag, S. Mantero, M. Birchall, A. Bader, and P. Macchiarini Both epithelial cells and mesenchymal stem cell-derived chondrocytes contribute to the survival of tissue-engineered airway transplants in pigs J. Thorac. Cardiovasc. Surg., February 1, 2010; 139(2): 437 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsukada, A. Ernst, S. Gangadharan, S. Ashiku, R. Garland, D. Litmanovich, and M. DeCamp Tracheal Replacement With a Silicone-Stented, Fresh Aortic Allograft in Sheep Ann. Thorac. Surg., January 1, 2010; 89(1): 253 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Makris, M. Holder-Espinasse, A. Wurtz, A. Seguin, T. Hubert, S. Jaillard, M. C. Copin, R. Jashari, M. Duterque-Coquillaud, E. Martinod, et al. Tracheal Replacement With Cryopreserved Allogenic Aorta Chest, January 1, 2010; 137(1): 60 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iyikesici, B. Tuncozgur, M. Sanli, A. F. Isik, F. Meteroglu, and L. Elbeyli Two-piece cryopreserved tracheal allotransplantation: an experimental study Eur J Cardiothorac Surg, October 1, 2009; 36(4): 722 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jungebluth, T. Go, A. Asnaghi, S. Bellini, J. Martorell, C. Calore, L. Urbani, H. Ostertag, S. Mantero, M. T. Conconi, et al. Structural and morphologic evaluation of a novel detergent-enzymatic tissue-engineered tracheal tubular matrix J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 586 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Davidson, K. Mustafa, and R. W. Girdwood Tracheal Replacement With an Aortic Homograft Ann. Thorac. Surg., September 1, 2009; 88(3): 1006 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brizzola, M. de Eguileor, T. Brevini, A. Grimaldi, T. Congiu, P. Neuenschwander, and F. Acocella Morphologic features of biocompatibility and neoangiogenesis onto a biodegradable tracheal prosthesis in an animal model Interact CardioVasc Thorac Surg, June 1, 2009; 8(6): 610 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Janssen, G. J. V. M. van Osch, J. P. Li, N. Kops, K. de Groot, J. W. Von den Hoff, L. Feenstra, and J. A. U. Hardillo Tracheal Reconstruction: Mucosal Survival on Porous Titanium Arch Otolaryngol Head Neck Surg, May 1, 2009; 135(5): 472 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Seguin, D. Radu, M. Holder-Espinasse, P. Bruneval, A. Fialaire-Legendre, M. Duterque-Coquillaud, A. Carpentier, and E. Martinod Tracheal Replacement With Cryopreserved, Decellularized, or Glutaraldehyde-Treated Aortic Allografts Ann. Thorac. Surg., March 1, 2009; 87(3): 861 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsukada, S. Matsuda, H. Inoue, Y. Ikada, and H. Osada Comparison of bioabsorbable materials for use in artificial tracheal grafts Interact CardioVasc Thorac Surg, February 1, 2009; 8(2): 225 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Gilbert, S. Gilbert, M. Madden, S. D. Reynolds, and S. F. Badylak Morphologic Assessment of Extracellular Matrix Scaffolds for Patch Tracheoplasty in a Canine Model Ann. Thorac. Surg., September 1, 2008; 86(3): 967 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-B. Ris, T. Krueger, C. Cheng, P. Pasche, P. Monnier, and L. Magnusson Tracheo-carinal reconstructions using extrathoracic muscle flaps Eur J Cardiothorac Surg, February 1, 2008; 33(2): 276 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abbasidezfouli, M. B. Shadmehr, M. Arab, M. Javaherzadeh, S. Pejhan, A. Daneshvar, and R. Farzanegan Postintubation Multisegmental Tracheal Stenosis: Treatment and Results Ann. Thorac. Surg., July 1, 2007; 84(1): 211 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Tan, R. Steiner, L. Yang, M. Welti, P. Neuenschwander, S. Hillinger, and W. Weder Accelerated angiogenesis by continuous medium flow with vascular endothelial growth factor inside tissue-engineered trachea Eur J Cardiothorac Surg, May 1, 2007; 31(5): 806 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ernst and S. Ashiku Tracheal Transplantation: Are We Any Closer to the Holy Grail of Airway Management? Chest, November 1, 2006; 130(5): 1299 - 1300. [Full Text] [PDF] |
||||
![]() |
S. Jaillard, M. Holder-Espinasse, T. Hubert, M.-C. Copin, M. Duterque-Coquillaud, A. Wurtz, and C.-H. Marquette Tracheal Replacement by Allogenic Aorta in the Pig Chest, November 1, 2006; 130(5): 1397 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Azorin, F. Bertin, E. Martinod, and M. Laskar Tracheal replacement with an aortic autograft Eur J Cardiothorac Surg, February 1, 2006; 29(2): 261 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Tintinago, D. A. Herrera, E. Medina, J. H. Patino, F. Cano, and C. S. Restrepo Ultrasonographic Evaluation of a Vascularized Tracheal Transplantation J. Ultrasound Med., August 1, 2005; 24(8): 1145 - 1149. [Full Text] [PDF] |
||||
![]() |
E. Martinod, A. Seguin, M. Holder-Espinasse, M. Kambouchner, M. Duterque-Coquillaud, J. F. Azorin, and A. F. Carpentier Tracheal Regeneration Following Tracheal Replacement With an Allogenic Aorta Ann. Thorac. Surg., March 1, 2005; 79(3): 942 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Carden, P. M. Boiselle, D. A. Waltz, and A. Ernst Tracheomalacia and Tracheobronchomalacia in Children and Adults: An In-depth Review Chest, March 1, 2005; 127(3): 984 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shi, Z. Xu, X. Qin, X. Zhao, and D. Lu Experimental Study of Replacing Circumferential Tracheal Defects With New Prosthesis Ann. Thorac. Surg., February 1, 2005; 79(2): 672 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walles, B. Giere, M. Hofmann, J. Schanz, F. Hofmann, H. Mertsching, and P. Macchiarini Experimental generation of a tissue-engineered functional and vascularized trachea J. Thorac. Cardiovasc. Surg., December 1, 2004; 128(6): 900 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Macchiarini, T. Walles, C. Biancosino, and H. Mertsching First human transplantation of a bioengineered airway tissue J. Thorac. Cardiovasc. Surg., October 1, 2004; 128(4): 638 - 641. [Full Text] [PDF] |
||||
![]() |
T. Walles, B. Giere, P. Macchiarini, and H. Mertsching Expansion of chondrocytes in a three-dimensional matrix for tracheal tissue engineering Ann. Thorac. Surg., August 1, 2004; 78(2): 444 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Macchiarini Trachea-guided generation: Deja vu all over again? J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 14 - 16. [Full Text] [PDF] |
||||
![]() |
J. Odell Invited commentary Ann. Thorac. Surg., February 1, 2004; 77(2): 405 - 405. [Full Text] [PDF] |
||||
![]() |
B. R. Beldholm, M. K. Wilson, R. M. Gallagher, D. Caminer, M. J. King, and A. Glanville Reconstruction of the trachea with a tubed radial forearm free flap J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 545 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, S. Korom, M. Welti, S. P. Hoerstrup, G. Zund, F. J. Jung, P. Neuenschwander, and W. Weder Tissue engineered cartilage generated from human trachea using DegraPol(R) scaffold Eur J Cardiothorac Surg, August 1, 2003; 24(2): 201 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Grillo Tracheal replacement J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 975 - 975. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |